|
|
||||||||
1Renal Division, Department of Medicine, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts; and 2Molecular Physiology Unit, Instituto de Investigaciones Biomiédicas, Universidad Nacional Autonoma de México and Instituto Nacional de Ciencias Médicas y Nutrición Salvador Zubirán, Mexico City, Mexico
Submitted 15 July 2005 ; accepted in final form 13 September 2005
Sensitive and specific biomarkers are needed to detect early kidney injury. The objective of the present work was to develop a sensitive quantitative urinary test to identify renal injury in the rodent to facilitate early assessment of pathophysiological influences and drug toxicity. Two mouse monoclonal antibodies were made against the purified ectodomain of kidney injury molecule-1 (Kim-1), and these were used to construct a sandwich Kim-1 ELISA. The assay range of this ELISA was 50 pg/ml to 5 ng/ml, with inter- and intra-assay variability of <10%. Urine samples were collected from rats treated with one of three doses of cisplatin (2.5, 5, or 7.5 mg/kg). At one day after each of the doses, there was an approximately three- to fivefold increase in the urine Kim-1 ectodomain, whereas other routinely used biomarkers measured in this study [plasma creatinine, blood urea nitrogen (BUN), urinary N-acetyl-
-glucosaminidase (NAG), glycosuria, proteinuria] lacked the sensitivity to show any sign of renal damage at this time point. When rats were subjected to increasing periods (10, 20, 30, or 45 min) of bilateral ischemia, there was an increasing amount of urinary Kim-1 detected. After only 10 min of bilateral ischemia, Kim-1 levels on day 1 were 10-fold higher (5 ng/ml) than control levels, whereas plasma creatinine and BUN were not increased and there was no glycosuria, increased proteinuria, or increased urinary NAG levels. Thus urinary Kim-1 levels serve as a noninvasive, rapid, sensitive, reproducible, and potentially high-throughput method to detect early kidney injury in pathophysiological studies and in preclinical drug development studies for risk-benefit profiling of pharmaceutical agents.
biomarkers; nephrotoxicity; enzyme-linked immunosorbent assay; cisplatin; ischemia; acute renal failure
This article has been cited by other articles:
![]() |
A. J. Rees and R. Kain Kim-1/Tim-1: from biomarker to therapeutic target? Nephrol. Dial. Transplant., September 3, 2008; (2008) gfn480v1. [Full Text] [PDF] |
||||
![]() |
E. Rached, D. Hoffmann, K. Blumbach, K. Weber, W. Dekant, and A. Mally Evaluation of Putative Biomarkers of Nephrotoxicity after Exposure to Ochratoxin A In Vivo and In Vitro Toxicol. Sci., June 1, 2008; 103(2): 371 - 381. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Zhang, R. P. Brown, M. Shaw, V. S. Vaidya, Y. Zhou, P. Espandiari, N. Sadrieh, M. Stratmeyer, J. Keenan, C. G. Kilty, et al. Immunolocalization of Kim-1, RPA-1, and RPA-2 in Kidney of Gentamicin-, Mercury-, or Chromium-Treated Rats: Relationship to Renal Distributions of iNOS and Nitrotyrosine Toxicol Pathol, April 1, 2008; 36(3): 397 - 409. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Wong, Y. Suzuki, C. Tanifuji, H. Akiba, K. Okumura, T. Sugaya, T. Yamamoto, S. Horikoshi, S. Y. Tan, C. Pollock, et al. Peritubular Ischemia Contributes More to Tubular Damage than Proteinuria in Immune-Mediated Glomerulonephritis J. Am. Soc. Nephrol., February 1, 2008; 19(2): 290 - 297. [Full Text] [PDF] |
||||
![]() |
M. Nepal, G. H. Bock, A. M. Sehic, M. F. Schultz, and P. L. Zhang Kidney Injury Molecule-1 Expression Identifies Proximal Tubular Injury in Urate Nephropathy Ann. Clin. Lab. Sci., January 1, 2008; 38(3): 210 - 214. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Zhou, V. S. Vaidya, R. P. Brown, J. Zhang, B. A. Rosenzweig, K. L. Thompson, T. J. Miller, J. V. Bonventre, and P. L. Goering Comparison of Kidney Injury Molecule-1 and Other Nephrotoxicity Biomarkers in Urine and Kidney Following Acute Exposure to Gentamicin, Mercury, and Chromium Toxicol. Sci., January 1, 2008; 101(1): 159 - 170. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Uehara, T. Miyoshi, N. Tsuchiya, K. Masuno, M. Okada, S. Inoue, M. Torii, J. Yamate, and T. Maruyama Comparative analysis of gene expression between renal cortex and papilla in nedaplatin-induced nephrotoxicity in rats Human and Experimental Toxicology, October 1, 2007; 26(10): 767 - 780. [Abstract] [PDF] |
||||
![]() |
P. Espandiari, J. Zhang, B. A. Rosenzweig, V. S. Vaidya, J. Sun, L. Schnackenberg, E. H. Herman, A. Knapton, J. V. Bonventre, R. D. Beger, et al. The Utility of a Rodent Model in Detecting Pediatric Drug-Induced Nephrotoxicity Toxicol. Sci., October 1, 2007; 99(2): 637 - 648. [Abstract] [Full Text] [PDF] |
||||
![]() |
Z. Zhang, B. D. Humphreys, and J. V. Bonventre Shedding of the Urinary Biomarker Kidney Injury Molecule-1 (KIM-1) Is Regulated by MAP Kinases and Juxtamembrane Region J. Am. Soc. Nephrol., October 1, 2007; 18(10): 2704 - 2714. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Chen, E. A. Bridenbaugh, A. D. Akintola, J. M. Catania, V. S. Vaidya, J. V. Bonventre, A. C. Dearman, H. W. Sampson, D. C. Zawieja, R. C. Burghardt, et al. Increased susceptibility of aging kidney to ischemic injury: identification of candidate genes changed during aging, but corrected by caloric restriction Am J Physiol Renal Physiol, October 1, 2007; 293(4): F1272 - F1281. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Liangos, M. C. Perianayagam, V. S. Vaidya, W. K. Han, R. Wald, H. Tighiouart, R. W. MacKinnon, L. Li, V. S. Balakrishnan, B. J.G. Pereira, et al. Urinary N-Acetyl-beta-(D)-Glucosaminidase Activity and Kidney Injury Molecule-1 Level Are Associated with Adverse Outcomes in Acute Renal Failure J. Am. Soc. Nephrol., March 1, 2007; 18(3): 904 - 912. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Perez-Rojas, J. A. Blanco, C. Cruz, J. Trujillo, V. S. Vaidya, N. Uribe, J. V. Bonventre, G. Gamba, and N. A. Bobadilla Mineralocorticoid receptor blockade confers renoprotection in preexisting chronic cyclosporine nephrotoxicity Am J Physiol Renal Physiol, January 1, 2007; 292(1): F131 - F139. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. H. de Borst, M. M. van Timmeren, V. S. Vaidya, R. A. de Boer, M. B. A. van Dalen, A. B. Kramer, T. A. Schuurs, J. V. Bonventre, G. Navis, and H. van Goor Induction of kidney injury molecule-1 in homozygous Ren2 rats is attenuated by blockade of the renin-angiotensin system or p38 MAP kinase Am J Physiol Renal Physiol, January 1, 2007; 292(1): F313 - F320. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. M. van Timmeren, S. J. L. Bakker, V. S. Vaidya, V. Bailly, T. A. Schuurs, J. Damman, C. A. Stegeman, J. V. Bonventre, and H. van Goor Tubular kidney injury molecule-1 in protein-overload nephropathy Am J Physiol Renal Physiol, August 1, 2006; 291(2): F456 - F464. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Devarajan Update on Mechanisms of Ischemic Acute Kidney Injury J. Am. Soc. Nephrol., June 1, 2006; 17(6): 1503 - 1520. [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |